Abstract
Recent reports of SARS-CoV-2 Omicron variant sub-lineages, BA.1, BA.1.1, and BA.2, have reignited concern over potential escape from vaccine- and infection-induced immunity. We examine the sensitivity of these sub-lineages and other major variants to neutralizing antibodies from mRNA-vaccinated and boosted individuals, as well as recovered COVID-19 patients, including those infected with Omicron. We find that all Omicron sub-lineages, especially BA.1 and BA.1.1, exhibit substantial immune escape that is largely overcome by mRNA vaccine booster doses. While Omicron BA.1.1 escapes almost completely from neutralization by early-pandemic COVID-19 patient sera and to a lesser extent from sera of Delta-infected patients, BA.1.1 is sensitive to Omicron-infected patient sera. Critically, all Omicron sub-lineages, including BA.2, are comparably neutralized by Omicron patient sera. These results highlight the importance of booster vaccine doses for protection against all Omicron variants and provide insight into the immunity from natural infection against Omicron sub-lineages.
Keywords: BA.1; BA.1.1; BA.2; COVID-19; Omicron; SARS-CoV-2; mRNA vaccine; neutralizing antibody.
【저자키워드】 COVID-19, neutralizing antibody, SARS-CoV-2, mRNA vaccine, omicron, BA.1, BA.2, BA.1.1, 【초록키워드】 neutralizing antibody, Vaccine, Immunity, Neutralizing antibodies, mRNA vaccine, neutralization, variant, omicron, sensitivity, Immune escape, mRNA, sera, natural infection, lineages, patients, Booster vaccine, Recovered COVID-19 patients, dose, COVID-19 patient, booster doses, patient sera, while, recent, neutralized, highlight, overcome, individuals,